ArticleFrontiers in immunology2022

Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer.

Xinyi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.